$15.43
-0.14-0.9%
Last update: Nov 6, 4:50 PM
Ultragenyx Pharmaceutical Inc (RARE) Stock Price, Quote, News & History
RARENASDAQ
Ultragenyx cuts 20% of staff and trims pipeline programs after missing Q3 targets, aiming for 2027 profitability through new commercial launches.
You can purchase shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) through any online brokerage.
Other companies in Ultragenyx Pharmaceutical’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Ultragenyx Pharmaceutical has a consensus price target of $46.19.
The stock price for Ultragenyx Pharmaceutical (NASDAQ: RARE) is $15.43 last updated November 6, 2026 at 4:50 PM EST.
There are no upcoming dividends for Ultragenyx Pharmaceutical.
Ultragenyx Pharmaceutical does not have any upcoming earnings scheduled.
There is no upcoming split for Ultragenyx Pharmaceutical.
Ultragenyx Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic...
